Efficacy and safety of avatrombopag in combination with standard immunosuppressive therapy for severe aplastic anemia
{{output}}
Severe aplastic anemia (SAA) is a life-threatening bone marrow failure disease. The addition of eltrombopag to immunosuppressive therapy (IST) improves the response rate, but its hepatotoxicity is concerning. Avatrombopag (AVA), a small-molecule thrombopoietin... ...
